Necrotizing enterocolitis: a multifactorial disease with no cure.

Area of Science:

• Neonatal Medicine
• Gastroenterology
• Inflammatory Bowel Disease

Background:

• Necrotizing enterocolitis (NEC) is a critical gastrointestinal disease affecting premature infants, characterized by high morbidity and mortality.
• The multifactorial nature of NEC and limitations in current disease models hinder early diagnosis and understanding of its pathogenesis.
• While preterm birth, hypoxia, formula feeding, and gut microbiota are known risk factors, the roles of genetics and inflammatory mediators remain unclear.

Purpose of the Study:

• To highlight the challenges in diagnosing and understanding the pathogenesis of necrotizing enterocolitis in neonates.
• To review current understanding of NEC risk factors and limitations in existing therapeutic strategies.
• To emphasize the need for improved disease models and novel therapeutic approaches.

Main Methods:

• Review of existing literature on necrotizing enterocolitis.
• Analysis of established and potential risk factors for NEC.
• Discussion of current treatment limitations and preventative strategies.

Main Results:

• Breastfeeding is identified as the most effective preventative measure for NEC.
• Recent research focuses on bioactive nutrients and trophic factors in human milk for NEC prevention.
• Current treatments for NEC are primarily symptomatic and surgically invasive, lacking targeted therapeutic action.

Conclusions:

• Improved understanding of NEC pathogenesis requires advanced disease models that incorporate prematurity and multiple risk factors.
• Development of innovative therapeutics targeting specific underlying disease processes is crucial.
• Further research into the genetic and mediator roles in NEC is needed to advance treatment and prevention.